Exagen Inc. XGN Accrued expenses and other liabilities
Accrued expenses and other liabilities at other companies
Other financials
Where this comes from
Reported directly by Exagen Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: Exagen Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exagen Inc.'s accrued expenses and other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exagen Inc.'s accrued expenses and other liabilities?
- Exagen Inc. (XGN) reported accrued expenses and other liabilities of -$1.56M in Q1 2026.
- How has Exagen Inc.'s accrued expenses and other liabilities changed year-over-year?
- Exagen Inc.'s accrued expenses and other liabilities decreased by 9.8% year-over-year, from -$1.42M to -$1.56M.
- What is the long-term trend for Exagen Inc.'s accrued expenses and other liabilities?
- Over 2 years (2021 to 2025), Exagen Inc.'s accrued expenses and other liabilities has grown at a -49.5% compound annual growth rate (CAGR), from $984K to $251K.